Mozavaptan is a potent vasopressin V2 receptor antagonist classified as an antidiuretic hormone inhibitor, primarily indicated for the treatment of conditions involving water imbalance, such as nephrogenic… Read more
Mozavaptan is a potent vasopressin V2 receptor antagonist classified as an antidiuretic hormone inhibitor, primarily indicated for the treatment of conditions involving water imbalance, such as nephrogenic diabetes insipidus. By blocking the action of antidiuretic hormone in the kidneys, this pharmaceutical agent helps regulate fluid retention and excessive urine production. This category features Mozavaptan and its related compounds, including synthetic impurities and stable isotope labelled standards, which are essential for rigorous pharmaceutical analysis. Laboratories utilize these high-quality reference standards for impurity profiling, method validation, and stability testing to ensure the integrity of the active pharmaceutical ingredient. Stable isotope labelled compounds, such as deuterium-labelled variants, serve as critical internal standards for quantitative analysis in mass spectrometry and high-performance liquid chromatography, allowing researchers to achieve accurate measurements during quality control procedures and regulatory submission processes.